Nanjing Cuccess Pharmaceutical

Nanjing Cuccess Pharmaceutical operates as a division of Nanjing Hanxin Pharmaceutical, a subsidiary of AMPHASTAR Group, a publicly traded company in the United States. Our focus lies in the development and production of biopharmaceuticals, encompassing recombinant drugs such as Peptides (e.g., Semaglutide, Liraglutide), Enzymes (e.g., CPB, KEX II Protease, Enterokinase, Trypsin), as well as ingredients for personal care and cosmetics (e.g., PDRN, Ergothioneine, Hyaluronic Acid, Humaniz...).